Industry News
Pharmaceutical Industry News
Is Your Medicine Cabinet a Mess?
Here’s what to toss, what to keep and how to store your drugs safely.
The company announced a phase 3…
The company announced a phase 3 win in the rare neurodegenerative disease Ataxia-Telangiectasia on the same day it snagged a key European approval in the drug's original indication of Niemann-Pick disease type C.
While much of the biopharma…
While much of the biopharma industry has spent the past 12 months treading lightly around the Trump administration and the tumult it has wrought on U.S. medical research and regulation, Pfizer’s CEO cut to the
Curia Global is laying off 81…
Curia Global is laying off 81 employees as part of its plan to shut down its drug product development and manufacturing facility in Burlington, Massachusetts, according to a Worker Adjustment and Retraining Notification.
GSK, through its oncology…
GSK, through its oncology subsidiary Tesaro, is handing over $20 million upfront to Alteogen for global rights to the Korean biotech’s novel hyaluronidase ALT-B4. Tesaro plans to use ALT-B4 to develop and potentially market a
Takeda is executing another round…
Takeda is executing another round of layoffs, cutting 243 roles in the United States. The company is preparing for an upcoming patent loss on depression drug Trintellix.
Roche is more than doubling its…
Roche is more than doubling its total commitment to a future facility for its Genentech unit to approximately $2 billion. The plant, being built in Holly Springs, North Carolina, will be used to crank out
As it inches closer to FDA…
As it inches closer to FDA submissions for its psychedelic drug candidate, Definium Therapeutics is laying the groundwork for a future launch with an educational push about the pharmaceutical potential of LSD.
The U.S. Supreme Court will hear a…
The U.S. Supreme Court will hear a case involving the "skinny label" practice of generic drugmakers, with its review particularly relating to Hikma's marketing of its generic version of Amarin's Vascepa.
9 mitos sobre la salud de las mujeres
Cuando se trata de la salud del corazón, la inmunidad, la reproducción y otros aspectos, abundan las ideas falsas.
As the U.S. government intensifies…
As the U.S. government intensifies efforts to acquire Greenland, President Donald Trump has responded to European pushback with a new, targeted tariff threat that risks upending the trade deal reached with the EU last summer.
Following an FDA marketing…
Following an FDA marketing suspension, Valneva has decided to voluntarily withdraw its chikungunya vaccine Ixchiq in the U.S. The FDA has also opened an investigation into a newly reported serious adverse event.
Five weeks after telling investors…
Five weeks after telling investors to expect a revenue decline in 2026, Pfizer has found a quick funding fix, selling off its stake in GSK’s ViiV Healthcare. The New York powerhouse has agreed to surrender
Prefilled drug delivery device…
Prefilled drug delivery device specialist Apiject has signed a lease for a new site in Apex, North Carolina, that will house two blow-fill-seal production lines.
Weight-Loss Drugs Could Save U.S. Airlines $580 Million Per Year
A study by the financial firm Jefferies highlights a surprising perk for carriers: lower fuel costs as slimmer passengers lighten their aircraft’s loads.
New York Sues Former C.E.O. of Covid Vaccine Maker Over Insider Trading
Robert G. Kramer sold nearly 90,000 shares of his stock in Emergent BioSolutions, knowing that large quantities of vaccine materials were contaminated, the lawsuit said.
Just days after AbbVie unveiled a…
Just days after AbbVie unveiled a major new oncology play in the form of its high-dollar RemeGen collab, the Illinois drugmaker closed out the week with some mixed news for marketed cancer offering Epkinly.
Amid a viral social media trend…
Amid a viral social media trend glorifying the halcyon days of 2016, Novo Nordisk has gone back an extra decade to find inspiration for its latest direct-to-consumer Ozempic campaign.
With Fujifilm Biotechnologies now…
With Fujifilm Biotechnologies now among the top echelon of CDMOs by biologics capacity, Fujifilm’s group CEO reflected on the unit’s unique facility design philosophy and how it’s eschewing big M&A plays to expand in-house.
For the fourth year running—and…
For the fourth year running—and the third in a row for Skyrizi specifically—an AbbVie immunology med has claimed the top spot in the full-year TV drug ad spending rankings.